Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated just now
Peer-reviewedCC BY 4.0Medicine

Association between inpatient aspirin exposure and 28-day mortality in critically ill patients with sepsis-induced coagulopathy: A cohort study

5 affiliations
  1. 1Department of Emergency Medicine, Quanzhou First Hospital Affiliated to Fujian Medical University, Quanzhou, Fujian, China
  2. 2Department of Infectious Disease, Beijing Luhe Hospital, Capital Medical University, Beijing, China
  3. 3Department of General practice, Quanzhou First Hospital Affiliated to Fujian Medical University, Quanzhou, China
  4. 4Department of Emergency, The First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, China
  5. 5Department of Emergency, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, China.

Abstract

This study aimed to evaluate the association between inpatient aspirin exposure and 28-day mortality in critically ill patients with sepsis-induced coagulopathy (SIC). We conducted a retrospective cohort study extracting data from the MIMIC-IV v3.1 database (2008–2022). Adult critically ill patients with SIC in the intensive care unit (ICU) were included. The primary outcome was 28-day mortality. Secondary outcomes encompassed mortality (e.g., in-hospital, ICU, 60-day, 90-day, and 1-year) and duration of ICU-free, ventilation-free, or vasopressor-free days within 28 days of admission to the ICU. Multivariable Cox regression, propensity score matching (PSM), inverse probability of treatment weighting (IPTW), overlap weighting (OW), pairwise algorithmic weighting (PA), and doubly robust estimation were employed to control confounders. Robustness of findings was assessed through subgroup and sensitivity analyses. Among 9095 critically ill patients with SIC, 3207 (35.3%) received aspirin during ICU hospitalization. After 1:1 propensity score matching (2069 pairs), inpatient aspirin exposure was independently associated with significantly lower 28-day mortality (hazard ratio [HR] 0.74; 95% confidence interval [CI]: 0.65–0.85; P < .001). This association remained consistent across multiple analytical methods including IPTW (HR 0.76; 95% CI: 0.70–0.84; P < .001), OW (HR 0.72; 95% CI: 0.61–0.84; P < .001), PA (HR 0.73; 95% CI: 0.61–0.84; P < .001), and doubly robust estimation (HR 0.76; 95% CI: 0.61–0.94; P < .001). Inpatient aspirin exposure was also associated with more favorable secondary clinical outcomes (all P < .001). In critically ill patients with SIC, inpatient aspirin exposure was independently associated with lower 28-day mortality and more favorable clinical outcomes. These findings should be interpreted as an association rather than evidence of a causal therapeutic effect. Prospective randomized studies are warranted to validate these findings.

Related

  1. Development and validation of a nomogram for predicting 28-day mortality in critically ill liver cirrhotic patients with coagulopathy
    Yongxu Lin, Liqin Wei, Xujin Wei +3
    BMC GastroenterologyPeer-reviewedCC BY-NC-ND 4.0Full textGeneral medicinePMCDOAJ
  2. Temporal patterns of respiratory rate exposure and mortality in critically ill patients: a retrospective multi-database cohort study
    Jingqing Xu, Min Li, Zhulin Wang +4
    Frontiers in medicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Association of first-24-hour hypernatremia and hyperkalemia co-occurrence with 30-day mortality in critically ill adults: a retrospective cohort study
    Wei-Hung Chang, Kuan-Pen Yu, Li-Kuo Kuo +2
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textGeneral medicineCrossref
  4. Age and the association between admission platelet count and in-hospital mortality in critically ill children
    Zhongbo Xu, Wenshui Lou, Jianqing Chen +7
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textEpidemiology & public healthCrossref
  5. Nonlinear association between cockcroft-gault creatinine clearance and all-cause mortality in critically ill cerebrovascular disease patients: a retrospective cohort study
    Hui Wang
    Scientific ReportsPeer-reviewedCC BYFull textGeneral medicineDOAJ
BibTeX
@article{zheng2026association,
  title = {{Association between inpatient aspirin exposure and 28-day mortality in critically ill patients with sepsis-induced coagulopathy: A cohort study}},
  author = {Jiantao Zheng and Yinying Wang and Chanjuan Zhou and Siming Lin},
  journal = {Medicine},
  year = {2026},
  month = nov,
  doi = {10.1097/md.0000000000051494},
  url = {https://doi.org/10.1097/md.0000000000051494},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Association between inpatient aspirin exposure and 28-day mortality in critically ill patients with sepsis-induced coagulopathy: A cohort study
AU  - Jiantao Zheng
AU  - Yinying Wang
AU  - Chanjuan Zhou
AU  - Siming Lin
PY  - 2026
DA  - 2026/11/06
JO  - Medicine
DO  - 10.1097/md.0000000000051494
UR  - https://doi.org/10.1097/md.0000000000051494
AB  - This study aimed to evaluate the association between inpatient aspirin exposure and 28-day mortality in critically ill patients with sepsis-induced coagulopathy (SIC). We conducted a retrospective cohort study extracting data from the MIMIC-IV v3.1 database (2008–2022). Adult critically ill patients with SIC in the intensive care unit (ICU) were included. The primary outcome was 28-day mortality. Secondary outcomes encompassed mortality (e.g., in-hospital, ICU, 60-day, 90-day, and 1-year) and duration of ICU-free, ventilation-free, or vasopressor-free days within 28 days of admission to the ICU. Multivariable Cox regression, propensity score matching (PSM), inverse probability of treatment weighting (IPTW), overlap weighting (OW), pairwise algorithmic weighting (PA), and doubly robust estimation were employed to control confounders. Robustness of findings was assessed through subgroup and sensitivity analyses. Among 9095 critically ill patients with SIC, 3207 (35.3%) received aspirin during ICU hospitalization. After 1:1 propensity score matching (2069 pairs), inpatient aspirin exposure was independently associated with significantly lower 28-day mortality (hazard ratio [HR] 0.74; 95% confidence interval [CI]: 0.65–0.85; P < .001). This association remained consistent across multiple analytical methods including IPTW (HR 0.76; 95% CI: 0.70–0.84; P < .001), OW (HR 0.72; 95% CI: 0.61–0.84; P < .001), PA (HR 0.73; 95% CI: 0.61–0.84; P < .001), and doubly robust estimation (HR 0.76; 95% CI: 0.61–0.94; P < .001). Inpatient aspirin exposure was also associated with more favorable secondary clinical outcomes (all P < .001). In critically ill patients with SIC, inpatient aspirin exposure was independently associated with lower 28-day mortality and more favorable clinical outcomes. These findings should be interpreted as an association rather than evidence of a causal therapeutic effect. Prospective randomized studies are warranted to validate these findings.
SN  - 0025-7974
SN  - 1536-5964
ER  -